IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

盘前交易 10-07 04:22:11 EDT

1.39

-0.03

-2.11%

最高1.45	最低1.35	成交量4.56万
今开1.43	昨收1.42	日振幅7.04%
总市值1,369万	流通市值999.49万	总股本984.71万
成交额6.39万	换手率0.63%	流通股本719.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.39,"timestamp":1791316800000,"preClose":1.42,"halted":0,"volume":45589,"delay":0,"changeRate":-0.021126760563380302,"floatShares":7190599,"shares":9847100,"eps":-1.8935153,"marketStatus":"盘前交易","change":-0.03,"latestTime":"10-07 04:22:11 EDT","open":1.425,"high":1.45,"low":1.35,"amount":63945.2102584,"amplitude":0.070423,"askPrice":1.58,"askSize":100,"bidPrice":1.21,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.8935153,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":1,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.39,"postHourTrading":{"tag":"盘后","latestPrice":1.39,"preClose":1.39,"latestTime":"19:30 EDT","volume":48,"amount":69.14,"timestamp":1791329402678,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7177606753263254},"requestUrl":"/m/hq/s/INAB","defaultTab":"news","newsList":[{"id":"2518227447","title":"In8Bio, Inc.盘中异动 早盘大幅拉升6.16%报0.262美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227447?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，In8Bio, Inc.股票出现异动，股价快速拉升6.16%。截至发稿，该股报0.262美元/股，成交量9.8859万股，换手率0.14%，振幅0.12%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923787","title":"In8Bio, Inc.盘中异动 下午盘急速上涨5.06%报0.272美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517923787?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:13","pubTimestamp":1741202030,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时13分，In8Bio, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报0.272美元/股，成交量95.0162万股，换手率1.31%，振幅9.66%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677326","title":"In8Bio, Inc.盘中异动 大幅下挫5.77%报0.245美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677326?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，In8Bio, Inc.股票出现异动，股价快速下挫5.77%。截至发稿，该股报0.245美元/股，成交量15.6197万股，换手率0.22%，振幅1.62%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516232634","title":"In8Bio, Inc.盘中异动 早盘大幅拉升5.65%报0.284美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516232634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516232634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:43","pubTimestamp":1741013001,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时43分，In8Bio, Inc.股票出现波动，股价急速上涨5.65%。截至发稿，该股报0.284美元/股，成交量33.8984万股，换手率0.47%，振幅6.84%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224322a25d434a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224322a25d434a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516306298","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516306298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516306298?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:20","pubTimestamp":1740774007,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时20分，In8Bio, Inc.股票出现异动，股价快速上涨5.21%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010420079896c2c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010420079896c2c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331559","title":"In8Bio, Inc.盘中异动 快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331559?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:22","pubTimestamp":1740684149,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时22分，In8Bio, Inc.股票出现波动，股价急速跳水5.25%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032230a256bb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032230a256bb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514863046","title":"In8Bio, Inc.盘中异动 快速拉升6.19%报0.271美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514863046?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:32","pubTimestamp":1740591173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时32分，In8Bio, Inc.股票出现异动，股价快速上涨6.19%。截至发稿，该股报0.271美元/股，成交量58.9105万股，换手率0.81%，振幅6.62%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227013253a255212a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227013253a255212a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514011282","title":"In8Bio, Inc.盘中异动 早盘大幅下挫5.00%报0.258美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514011282?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:15","pubTimestamp":1740500131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时15分，In8Bio, Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报0.258美元/股，成交量72.7994万股，换手率1.00%，振幅6.51%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001531abdc9727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001531abdc9727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514777608","title":"In8Bio, Inc.盘中异动 急速拉升5.49%报0.286美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514777608?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:47","pubTimestamp":1740422820,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时47分，In8Bio, Inc.股票出现波动，股价急速拉升5.49%。截至发稿，该股报0.286美元/股，成交量112.362万股，换手率1.55%，振幅7.15%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024701abdb4536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024701abdb4536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513870215","title":"In8Bio, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513870215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513870215?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:47","pubTimestamp":1740160026,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时47分，In8Bio, Inc.股票出现波动，股价快速下跌5.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222014707988e096e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222014707988e096e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512200484","title":"In8Bio, Inc.盘中异动 临近午盘快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512200484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512200484?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:38","pubTimestamp":1739983110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时38分，In8Bio, Inc.股票出现波动，股价急速拉升5.96%。截至发稿，该股报0.283美元/股，成交量183.947万股，换手率2.54%，振幅9.06%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003831988b45ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003831988b45ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166752","title":"In8Bio, Inc.盘中异动 大幅跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166752?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，In8Bio, Inc.股票出现异动，股价急速下跌5.33%。截至发稿，该股报0.275美元/股，成交量104.3万股，换手率1.44%，振幅3.71%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822325396279756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822325396279756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696234","title":"In8Bio, Inc.盘中异动 早盘急速跳水5.11%报0.307美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696234?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543632,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分，In8Bio, Inc.股票出现异动，股价快速跳水5.11%。截至发稿，该股报0.307美元/股，成交量274.028万股，换手率3.78%，振幅3.34%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422335296231bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422335296231bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4007","BK4139","BK4539","VRPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511152520","title":"In8Bio, Inc.盘中异动 早盘股价大涨10.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511152520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511152520?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457064,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，In8Bio, Inc.股票出现波动，股价快速拉升10.04%。截至发稿，该股报0.320美元/股，成交量571.186万股，换手率7.88%，振幅0.96%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223104abcdb1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223104abcdb1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510434339","title":"Jones Trading：上调IN8bio(INAB.US)评级，由持有调整至买入评级, 目标价1.20美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510434339","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510434339?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:03","pubTimestamp":1739289826,"startTime":"0","endTime":"0","summary":"Jones Trading：上调IN8bio(INAB.US)评级，由持有调整至买入评级, 目标价1.20美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12000348092238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510337864","title":"In8Bio, Inc.盘中异动 早盘急速拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510337864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510337864?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:48","pubTimestamp":1739202508,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时48分，In8Bio, Inc.股票出现波动，股价大幅上涨5.73%。截至发稿，该股报0.275美元/股，成交量11.7311万股，换手率0.16%，振幅5.38%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234828abc9b5e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234828abc9b5e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509740952","title":"In8Bio, Inc.盘中异动 早盘快速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509740952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509740952?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:07","pubTimestamp":1738940842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时07分，In8Bio, Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报0.263美元/股，成交量15.4599万股，换手率0.21%，振幅5.38%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230722987db455&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230722987db455&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509774602","title":"In8Bio, Inc.盘中异动 急速下挫5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509774602?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:48","pubTimestamp":1738853298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时48分，In8Bio, Inc.股票出现异动，股价急速下挫5.68%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224818a23bd264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224818a23bd264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509282500","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.00%报0.267美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509282500?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:30","pubTimestamp":1738765853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时30分，In8Bio, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报0.267美元/股，成交量2.917万股，换手率0.04%，振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223053a23a79fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223053a23a79fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KTTA","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508097141","title":"In8Bio, Inc.盘中异动 股价大跌6.18%报0.240美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508097141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508097141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，In8Bio, Inc.股票出现异动，股价急速下跌6.18%。截至发稿，该股报0.240美元/股，成交量8.1071万股，换手率0.11%，振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223318abc1074f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223318abc1074f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":0.0734},{"period":"1month","weight":0.1583},{"period":"3month","weight":0.0072},{"period":"6month","weight":-0.028},{"period":"1year","weight":-0.4085},{"period":"ytd","weight":-0.406}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。该公司是一家领先的临床阶段生物制药公司，专注于癌症和自身免疫性疾病的gamma-delta T细胞治疗候选产品和gamma-delta T细胞接合剂的发现、开发和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.091988},{"month":2,"riseRate":0.4,"avgChangeRate":-0.06371},{"month":3,"riseRate":0.2,"avgChangeRate":-0.16139},{"month":4,"riseRate":0.4,"avgChangeRate":-0.056096},{"month":5,"riseRate":0.6,"avgChangeRate":0.263753},{"month":6,"riseRate":0.2,"avgChangeRate":-0.30708},{"month":7,"riseRate":0.4,"avgChangeRate":-0.072897},{"month":8,"riseRate":0.5,"avgChangeRate":-0.113897},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.08639},{"month":10,"riseRate":0.5,"avgChangeRate":-0.000484},{"month":11,"riseRate":0.4,"avgChangeRate":-0.077155},{"month":12,"riseRate":0.6,"avgChangeRate":0.153062}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}